$8.3B package for coronavirus approved

Amy Baxter | | Health Exec | Policy & Regulations
Medical societies are asking Congress to be involved in Medicare reform efforts.

Congress approved an $8.3 billion package to fight the spread of coronavirus and respond to the crisis.

While the vast majority of the cases of coronavirus, dubbed COVID-19, remain in China, at least 60 other locations have confirmed cases. In the U.S., nine deaths and 80 confirmed cases have been reported by the CDC as of March 4. The CDC also expects more cases to pop up in the nation as testing advances and accelerates.

The coronavirus package includes $950 million to states, localities, territories and tribes to help with virus surveillance, lab testing and infection control. $3 billion has been earmarked for research and development of COVID-19 vaccines, therapeutics and diagnostics. Other provisions for waiving Medicare telehealth restrictions were also included, as telehealth could potentially help diagnose the virus without spreading it further.

Another $2.2 billion was allocated for public health measures to prevent the spread of the virus, while $1 billion will be sent overseas to aid in preventing further spread under the House bill.

The spending package, which was passed by the house on March 4, will go to the Senate for approval and, ultimately, President Trump’s desk for signature. The Trump administration originally asked Congress to approve $2.5 billion in funding to fight the disease, but the figure was met with criticism from experts.

Health agencies are also ramping up testing for the virus domestically.

"We have more than 2,500 kits that are being distributed around the country this week that will make more than 1.5 million tests available at hospitals that have requested them and in areas of the country that have been particularly impacted by the coronavirus," Vice President Mike Pence, who is heading up the U.S. response to COVID-19, said in a statement March 4.

 

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Report: UnitedHealth under investigation by DOJ for Medicare Advantage upcoding
FDA approves first therapy for very rare lipid storage disorder
FDA announces Class I recall of Boston Scientific pacemakers—replacement may be necessary
FDA ends semaglutide shortage, closing the door on compounded Wegovy, Ozempic
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues
Federal judge sides with FTC; case against PBMs to move forward

Around the web

Cardiovascular Business
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

Cardiovascular Business
Cardiologist questions FDA’s approval process for high-risk medical devices

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

Cardiovascular Business
FDA announces new recall of Johnson & Johnson heart pumps over safety concerns

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”